Xcout Intel
RefinedScience
RefinedScience provides a data platform and solutions for drug development, integrating clinical data, single-cell human biology, and functional testing to help pharmaceutical and biotechnology companies with target discovery, translational validation, and clinical trial support.
Subscribe to see RefinedScience’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
RefinedScience at a glance
RefinedScience is a biotech company. Xcout tracks 18 named people at RefinedScience, including Brett Atwood (President). Xcout recorded 1 job posting from RefinedScience in the last 90 days.
RefinedScience leadership
- Brett AtwoodPresident
- Grant WellerChief Technology Officer
- Chris RusconiChief Scientific Officer
- Clay SmithChief Innovation Officer
- Dan PollyeaChief Medical Officer
- Jeff WenessVP, Growth & Strategy
12 more named people on record for RefinedScience, with roles, board committees and tenure — see the full roster →
Hiring at RefinedScience
Xcout recorded 1 job posting from RefinedScience in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see RefinedScience's hiring signals →
RefinedScience competitors
A few of RefinedScience's closest competitors — see the full list of competitors and alternatives →
Watershed Informatics provides a comprehensive bioinformatics and data analysis platform designed for life sciences researchers and biotechnology companies. The platform automates data processing, supports multi-omics applications, and facilitates collaboration for users ranging from bench biologists to expert data scientists.
Nova In Silico provides a collaborative clinical trial simulation platform called jinkō, which uses disease models and virtual patient populations to predict clinical outcomes. The company serves pharmaceutical and biotech organizations by helping them optimize trial design, reduce risks to human subjects, and accelerate drug development from discovery to market access.
Novadiscovery provides a collaborative clinical trial simulation platform called jinkō that uses disease models and digital patients to predict clinical outcomes. The company serves pharmaceutical and life sciences organizations by optimizing trial design, reducing risks to human subjects, and accelerating drug development from discovery to market access.
CureHunter provides an evidence-based medical search, data retrieval, and analysis engine for clinical decision support and pharmaceutical research.
Get RefinedScience's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about RefinedScience? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on RefinedScience in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access